Safety Study of Rufinamide Given as an add-on Therapy to Treat Patients With Seizures
Status:
Withdrawn
Trial end date:
2008-12-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the efficacy and safety of Rufinamide in reducing seizure frequency
in subjects with partial seizures not fully controlled despite treatment with 1 to 3
concomitant antiepileptic drugs.